生殖尿路癌新辅助疗法:当前和未来的方法
Sujit S Nair1, Dimple Chakravarty1, Vaibhav Patel2
1Department of Urology and Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Trends in cancer
|September 8, 2023
概括
新辅助疗法对生殖尿路 (GU) 癌症具有显著的益处,改善治疗反应和患者的治疗结果. 未来的精确瘤学将利用生物标志物分层试验用于局部和局部发达的GU恶性瘤.
科学领域:
- 在瘤学瘤学.
- 生殖尿路 (GU) 恶性瘤
- 精准医学是一门精准的医学.
背景情况:
- 新辅助疗法提高治疗耐受性,减少癌症护理手术前的瘤负担.
- 人们越来越感兴趣将新辅助疗法应用于生殖尿道 (GU) 癌症,以改善存活率和减少复发.
- 目前新辅助剂的使用在膀癌中是标准的,但仅限于癌和前列腺癌 (PCa) 的试验.
研究的目的:
- 在GU恶性瘤中审查新辅助药研究.
- 讨论这些研究如何为未来的临床试验设计提供信息.
- 突出精确新辅助疗法在GU癌症中的潜力.
主要方法:
- 审查现有的新辅助药在生殖尿路癌症的研究.
- 对临床试验数据和结果的分析.
- 讨论生物标志物分层和相关研究.
主要成果:
- 新辅助疗法在未经治疗的患者中非常有效,产生显著的药物反应.
- 结果不会被之前或同时进行的抗癌治疗所混.
- 具有强大的终点的生物标志物分层试验对于推进新辅助治疗至关重要.
结论:
- 新辅助疗法对改善局部和局部晚期GU癌症的结果有着巨大的前景.
- 新辅助治疗的未来在于精密瘤学,以生物标志物为指导.
- 进一步的研究和生物标志物驱动的临床试验对于优化GU恶性瘤中新辅助剂策略至关重要.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy
554
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
554
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cancer Vaccines
399
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
399
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


